Women with first recurrence of endometrial cancer: who are they? An analysis of real-world data of the JAGO/NOGGO
The present study suggests that most patients with recurrent endometrial cancer are in relatively good overall health, allowing them to undergo anti-tumor treatment. In general, they live independently and prefer active treatment over best supportive care.
Authors
- Jalid Sehouli (ORCID: https://orcid.org/0000-0002-5963-6623)
- Julia Caroline Radosa (ORCID: https://orcid.org/0000-0003-2024-2907)
- Jens Hachenberg (ORCID: https://orcid.org/0000-0002-4542-5833)
- Irina Tsibulak (ORCID: https://orcid.org/0000-0001-6795-3015)
- Louisa Proppe (ORCID: https://orcid.org/0000-0003-1989-2267)
- Chiara Flethe
- Klaus Pietzner (ORCID: https://orcid.org/0000-0003-2056-1668)
- Christine Botscharnikow
- Julia Zimmermann (ORCID: https://orcid.org/0000-0003-0741-8664)
- Teresa Lucia Pan (ORCID: https://orcid.org/0009-0004-2101-0811)
Institutions
- Gynecologic Oncology Group (US)
- Innsbruck Medical University (AT)
- Medizinische Hochschule Hannover (DE)
- Humboldt-Universität zu Berlin (DE)
- Universitäres Kinderwunschzentrum Lübeck (DE)
- University Hospital Münster (DE)
- University Hospital Schleswig-Holstein (DE)
- Saarland University (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1186/s12885-025-15168-8
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00